<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>61</patient-age><report-id>US-CELGENEUS-163-21880-13013522</report-id><gender>male</gender><reactions><reaction>EXPIRED</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>REVLIMID</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>10028233</indication></indications><outcomes><outcome>Death</outcome></outcomes><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
  <ichicsrmessageheader lang="en">
    <messagetype>ichicsr</messagetype>
    <messageformatversion>2.1</messageformatversion>
    <messageformatrelease>2.0</messageformatrelease>
    <messagenumb>CEL000000000001289238</messagenumb>
    <messagesenderidentifier>CELGENE</messagesenderidentifier>
    <messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
    <messagedateformat>204</messagedateformat>
    <messagedate>20130125102157</messagedate>
  </ichicsrmessageheader>
  <safetyreport lang="en">
    <safetyreportversion lang="en">0</safetyreportversion>
    <safetyreportid lang="en">US-CELGENEUS-163-21880-13013522</safetyreportid>
    <primarysourcecountry>US</primarysourcecountry>
    <occurcountry>US</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>2013-01-25</transmissiondate>
    <reporttype>1</reporttype>
    <serious code="1">Yes</serious>
    <seriousnessdeath>1</seriousnessdeath>
    <seriousnessother>1</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>2013-01-21</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>2013-01-21</receiptdate>
    <additionaldocument>2</additionaldocument>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb lang="en">US-CELGENEUS-163-21880-13013522</companynumb>
    <medicallyconfirm>1</medicallyconfirm>
    <linkedreport>
      <linkreportnumb>US-CELGENE-163-21880-13010252</linkreportnumb>
    </linkedreport>
    <primarysource>
      <reportergivename>Robert</reportergivename>
      <reporterfamilyname>Waldmann</reporterfamilyname>
      <reporterstreet>43555 Dalcoma Drive, Suite 8, Attn: Linda, Nurse</reporterstreet>
      <reportercity>Clinton Township</reportercity>
      <reporterstate>MI</reporterstate>
      <reporterpostcode>48038</reporterpostcode>
      <reportercountry>US</reportercountry>
      <qualification code="1">Physician</qualification>
    </primarysource>
    <sender>
      <sendertype>1</sendertype>
      <senderorganization>CELGENEUS</senderorganization>
      <senderdepartment>Global Drug Safety</senderdepartment>
      <sendertitle>Manager</sendertitle>
      <sendergivename>Vivian</sendergivename>
      <senderfamilyname>Fonseca</senderfamilyname>
      <senderstreetaddress>300 Connell Drive, Suite 6000</senderstreetaddress>
      <sendercity>Berkeley Heights</sendercity>
      <senderstate>NJ</senderstate>
      <senderpostcode>07922</senderpostcode>
      <sendercountrycode>US</sendercountrycode>
      <sendertel>9082190331</sendertel>
      <senderfax>9086739115</senderfax>
      <senderemailaddress>vfonseca@celgene.com</senderemailaddress>
    </sender>
    <receiver>
      <receivertype>2</receivertype>
      <receiverorganization>FDAPM</receiverorganization>
      <receivergivename>Roger</receivergivename>
      <receivermiddlename>A</receivermiddlename>
      <receiverfamilyname>Goetsch</receiverfamilyname>
      <receivercountrycode>US</receivercountrycode>
    </receiver>
    <patient lang="en">
      <patientinitial>H-C</patientinitial>
      <patientbirthdateformat>102</patientbirthdateformat>
      <patientbirthdate>19510905</patientbirthdate>
      <patientsex code="1">Male</patientsex>
      <patientmedicalhistorytext lang="en">None provided</patientmedicalhistorytext>
      <patientdeath>
        <patientdeathcause>
          <patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
          <patientdeathreport>10063378</patientdeathreport>
        </patientdeathcause>
      </patientdeath>
      <reaction>
        <primarysourcereaction lang="en">EXPIRED</primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>10011906</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>10011906</reactionmeddrapt>
        <termhighlighted>3</termhighlighted>
        <reactionoutcome code="5">fatal</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>REVLIMID</medicinalproduct>
        <obtaindrugcountry>US</obtaindrugcountry>
        <drugauthorizationnumb>21-880</drugauthorizationnumb>
        <drugauthorizationcountry>US</drugauthorizationcountry>
        <drugauthorizationholder>Celgene Corporation</drugauthorizationholder>
        <drugstructuredosagenumb>25</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugseparatedosagenumb>21</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>21</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
        <drugdosagetext lang="en">25 Milligram</drugdosagetext>
        <drugdosageform normalized="capsule">Capsules</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10028233</drugindication>
        <drugstartdateformat>102</drugstartdateformat>
        <drugstartdate>2011-11-18</drugstartdate>
        <actiondrug code="6">Not Applicable</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>LENALIDOMIDE</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10011906</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Unknown</drugresult>
        </drugreactionrelatedness>
      </drug>
      <summary lang="en">
        <narrativeincludeclinical><Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">EXPIRED</Semaphore>(USA) <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>information was received on 21/Jan/2013 from a <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>at the prescriber's office via a <Semaphore x="2472604" class="Procedure" value="Routine Histology Staining Method" score="1.00" ID="C23043">contract </Semaphore><Semaphore x="2394141" class="Occupation" value="Pharmacist" score="1.00" ID="C51840">pharmacy </Semaphore>regarding a <Semaphore x="1387834" class="Patient Age" value="61" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="61" score="1.00" ID="">61 </Semaphore>year old </Semaphore>male who received <Semaphore x="1131427" class="Medicine" value="Revlimid" score="0.74" ID="256603">Revlimid </Semaphore><Semaphore x="4859317408759809" class="Medicine - Revlimid - Dose" value="25mg" score="0.49" ID="">25mg </Semaphore><Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore>capsules once daily (21 every 21 days) from 18/Nov/2011 to an unknown date for the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma </Semaphore>without <Semaphore x="2458238" class="Disease or Finding" value="Remission" score="1.00" ID="C18246">remission</Semaphore>. Lot number was A0177A and expiration date was 31/Jan/2015. Relevant medical history and concomitant medications were unknown.It was reported the patient had <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">expired </Semaphore>on an unspecifed date. <Semaphore x="1728496" class="Disease or Finding" value="Cause of Death" score="1.00" ID="C81239">Cause of <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore></Semaphore>was not provided. It had previously been reported by the patient's <Semaphore x="2844144" class="MedDRA LLT" value="Caregiver" score="1.00" ID="10007664">caregiver </Semaphore>that the patient was in a <Semaphore x="1801434" class="Disease or Finding" value="Coma" score="1.00" ID="C34497">coma </Semaphore>(MCN 163-21880-13010252). The causal relationship of the patient's <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death </Semaphore>to <Semaphore x="1131427" class="Medicine" value="Revlimid" score="0.74" ID="256603">Revlimid </Semaphore>was reported as unknown. Additional information will be requested from the prescriber.This case was cross referenced to MCN 163-21880-13010252 (<Semaphore x="1801434" class="Disease or Finding" value="Coma" score="1.00" ID="C34497">coma</Semaphore>, <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">myocardial infarction</Semaphore>).</narrativeincludeclinical>
        <sendercomment lang="en">The temporal relationship between therapy and the patient's death [EXPIRED] suggests that a causal relationship is possible, but underlying multiple myeloma could provide an alternative explanation. Additional information regarding the patient's disease status prior to death, relevant medical history, concomitant medications, and circumstances of the event will be requested.</sendercomment>
      </summary>
    </patient>
  </safetyreport>
</ichicsr></original></faers>